Based on a shared molecular diagnosis, we could speculate that treatment with Alpelisib could be able to induce a reduction and an improvement also in isolated PIK3CA-related vascular malformations, such as venous or lymphatic malformations. The gene discussed is PIK3CA; the disease is vascular malformation.